Discover 1,900 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,900
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: New Haven CT, Quebec, New York NY, New Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Philadelphia PA, Richmond VA, Falls Church VA,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Recruiting
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06922591
Phase 1, Phase 2, Recruiting
Cast Art for Kids With Extremity Fractures
for
Fractures, Bone
Location: Portsmouth VA
Sponsor: United States Naval Medical Center, Portsmouth
Sex: All
Age: 5 - 18
Code: NCT06990555
Recruiting
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
for
Lung Neoplasm
Location: Baltimore MD, Fairfax VA, Lexington KY, Dallas TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780098
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07000084
Phase 3, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Location: Providence RI, Montreal, Virginia Beach VA,
Sponsor: Merit Medical Systems, Inc.
Sex: All
Age: 18+
Code: NCT06807099
Recruiting
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
for
Von Willebrand Disease, Type 3
Location: Montreal, Richmond VA, Toronto, Gainesville FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0+
Code: NCT06998524
Phase 3, Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
for
Hepatitis B Virus Infection
Location: Baltimore MD, Richmond VA, Peachtree Corners GA,
Sponsor: GigaGen, Inc.
Sex: All
Age: 18+
Code: NCT07024641
Phase 1, Recruiting
A Study of Emapalumab for Pediatric Aplastic Anemia
for
Aplastic Anemia, Cytopenia, Hypocellular Marrow
Location: New York NY, Philadelphia PA, Richmond VA,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 0 - 25
Code: NCT06430788
Phase 2, Recruiting
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
for
Cystic Fibrosis (CF)
Location: Boston MA, Richmond VA, Chapel Hill NC, Hollywood FL,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 1 - 11
Code: NCT07048574
Recruiting
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
for
Macular Edema
Location: Hagerstown MD, Wake Forest NC, Pompano Beach FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06962839
Phase 2, Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Charlottesville VA, Winston-Salem NC, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06015880
Phase 1, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: New York NY, Baltimore MD, Richmond VA, Margate FL,
Sponsor: NGM Biopharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07033026
Phase 2, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,